NCT00323011View on ClinicalTrials.gov

FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

November 30, 2007

Conditions
Colorectal Cancer
Interventions
DRUG

Fragmin, 5-Fluorouracil, Folinic Acid, irinotecan, bevacizumab

Trial Locations (1)

90033

USCNorris Hospital, Los Angeles

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Southern California

OTHER